ノースカロライナにおける乳がんの臨床試験
ノースカロライナ内の拠点で、乳がんに関する90件の研究が参加者を募集しています。
ノースカロライナ内の都市
- Durham63件の研究
- Charlotte22件の研究
- Winston-Salem14件の研究
- Concord5件の研究
- Shelby5件の研究
- Greensboro5件の研究
- Gastonia4件の研究
- High Point4件の研究
- Greenville4件の研究
- Asheville3件の研究
- Raleigh3件の研究
公式研究テキスト（英語）
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Duke University, Durham
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
- Novant Health Cancer Institute - Kernersville, Kernersville
- Novant Health Cancer Institute - Mount Airy, Mount Airy
- Novant Health Forsyth Medical Center, Winston-Salem
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Duke Cancer Network, Durham
- Cone Health Cancer Center, Greensboro
被験者募集中第3相
18歳〜100歳 · 全性別 · 2026/10/02更新 · NCT05827081Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AdventHealth Infusion Center Asheville, Asheville
- Southeastern Medical Oncology Center-Clinton, Clinton
- AdventHealth Infusion Center Haywood, Clyde
- 他6件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Levine Cancer, Charlotte
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07102381Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
- University of North Carolina, Chapel Hill
被験者募集中第2相健康なボランティア歓迎
18歳〜45歳 · 女性 · 2026/10/01更新 · NCT05557877A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06369285Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
- Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07360314Radiation Therapy and Thymus Function in Young Women With Breast Cancer
- Duke Cancer Center, Durham
被験者募集中観察研究
18歳〜50歳 · 女性 · 2026/09/29更新 · NCT07725172BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
- Duke Cancer Center, Durham
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06120283A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Novant Health Cancer Institute ( Site 0019), Charlotte
- Novant Health Oncology Specialists ( Site 0074), Winston-Salem
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07060807Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
- University of North Carolina, Chapel Hill
被験者募集中観察研究健康なボランティア歓迎
全年齢 · 全性別 · 2026/09/28更新 · NCT05440929Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
被験者募集中
30歳以上 · 女性 · 2026/09/25更新 · NCT02945579A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Levine Cancer Institute ( Site 0014), Charlotte
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06312176The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Levine Cancer Institute, Albemarle
- Levine Cancer Institute, Charlotte
- Levine Cancer Institute, Charlotte
- 他11件
被験者募集中第3相
60歳以上 · 全性別 · 2026/09/25更新 · NCT06377852ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Duke Cancer Institute, Durham
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07007559Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Charlotte
- Clinical Trial Site, Durham
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07085767Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Atrium Levine Cancer Institute, Charlotte
被験者募集中
18歳以上 · 全性別 · 2026/09/23更新 · NCT07214532A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Messino Cancer Centers, Asheville
- WakeMed Cancer Care - Waverly Hematology & Medical Oncology, Cary
- University of North Carolina Medical Center, Chapel Hill
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- University of North Carolina Medical Center, Chapel Hill
被験者募集中第2相
18歳以上 · 女性 · 2026/09/22更新 · NCT07287098A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Duke University Medical Center, Durham
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
- Atrium Health, Charlotte
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05894239Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07340541Identifying Patterns in the Breath of Individuals With Breast Cancer
- Duke University Medical Cente, Durham
被験者募集中観察研究健康なボランティア歓迎
40歳〜74歳 · 女性 · 2026/09/18更新 · NCT06512350ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Oncology Specialists of Charlotte Pa, Charlotte
- Carolina Oncology Specialists, Charlotte
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07173751Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07685938Utility of a Mobile Application for Young Women With Breast Cancer
- Atrium Health Levine Cancer, Charlotte
被験者募集中
18歳〜45歳 · 女性 · 2026/09/15更新 · NCT07009093A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Duke Cancer Institute, Durham
- Cape Fear Valley Medical Center, Fayetteville
- Cone Health Cancer Center at Wesley Long, Greensboro
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT06492616Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
- University of North Carolina at Chapel Hill, Chapel Hill
被験者募集中観察研究
20歳〜74歳 · 女性 · 2026/09/14更新 · NCT07214610A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Charlotte
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT05123482A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Duke Cancer Institute, Durham
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/10更新 · NCT03424005A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Duke Cancer Institute, Durham
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- Levine Cancer Institute, Charlotte
- Novant Health Cancer Institute, Charlotte
- Novant Health Oncology Specialists, Winston-Salem
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT07100106Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
- Duke Cancer Institute, Durham
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT05315700Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
- University of North Carolina, Chapel Hill
被験者募集中第2相
50歳以上 · 女性 · 2026/09/03更新 · NCT06902311Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
- Duke University, Durham
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT05846789A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Novant Health Cancer Institute, Charlotte
- Duke Cancer Institute, Durham
- Novant Health Cancer Institute, Winston-Salem
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06790693Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/09/02更新 · NCT07025785The Vanguard Study: Testing a New Way to Screen for Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Durham VA Medical Center, Durham
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Atrium Health Stanly/LCI-Albemarle, Albemarle
- Cone Health MedCenter Asheboro, Asheboro
- Cone Health Cancer Center at Alamance Regional, Burlington
- 他47件
被験者募集中第3相
18歳〜60歳 · 女性 · 2026/09/02更新 · NCT05879926ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。